Clinical Trials Directory

Trials / Unknown

UnknownNCT00740740

Biomarkers of Aneurysm Wall Strength

Biological and Biochemical Markers of Aneurysm Wall Degradation; Towards Non-Invasive Wall Strength Analysis.

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Radboud University Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to identify possible in vivo biochemical and biological markers related to aortic wall strength.

Detailed description

Rupture of an Abdominal Aortic Aneurysm (AAA) is potentially lethal. prophylactic surgical repair is therefore warranted when the risk of rupture exceeds the risk of complications following surgery. Aneurysm rupture occurs when the forces (stress) acting on the aneurysm wall surpass aneurysm wall strength. Information on both wall stress and strength might therefore improve rupture risk assessment and patient selection for prophylactic repair. Although aneurysm wall stress calculations are possible, no in vivo method exists to determine aneurysm wall strength. This study was designed to identify possible biomarkers of aneurysm wall strength

Conditions

Timeline

Start date
2007-06-01
Primary completion
2010-01-01
Completion
2010-01-01
First posted
2008-08-25
Last updated
2008-08-25

Locations

2 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00740740. Inclusion in this directory is not an endorsement.

Biomarkers of Aneurysm Wall Strength (NCT00740740) · Clinical Trials Directory